1. Triumvira’s TAC01-CD19 Receives FDA’s Fast Track Designation for R/R Diffuse Large B-Cell Lymphoma Published: Nov 07, 2019 | Tags: Triumvira, TAC01-CD19, Receives, FDA, Fast Track Designation, R/R, Diffuse Large B-Cell […]readmore
Tags : Wright Medical
Shots: Stryker to acquire Wright Medical in all cash transaction for $30.75/share or a total equity value of $4.0B, making a total deal value as $5.4B. The acquisition is expected […]readmore